The technology will allow scientists or clinicians to load crude blood sample and generate DNA sequencing libraries in a fully automated workflow.
SeraCare is licensing UCSF's T21, T18, and T13 trophoblast cell line materials to develop NIPT reference materials.
The NGS panel looks for mutations in KRAS, BRAF, EGFR, ROS1, and ALK and will be available through Admera's sales partner Rosetta Genomics.
The deal allows Floragenex to extend its SBG service offerings to include double digest RAD-Seq in non-commercial and academic research across all species.
The project aims to sequence nine different taxa of cultivated potato and one closely-related wild species to facilitate the production of improved varieties of the crop.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.
The New York Times' George Johnson muses on cancer's roots in multicellularity.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.